Manatt Health counsel Allison Orris was featured in a Q&A with HealthLeaders, where she offered her perspective on CMS’ recently released Medicaid block grant guidance, and described some of the concerns stakeholders are raising about the proposal. In this article, Orris noted that the guidance “appears to shift a lot of financial risk to states, giving them less money than they would get under a traditional Medicaid expansion in exchange for some new forms of flexibility, but not sweeping forms of flexibility. Still, the consequences in a state that picks up the option could be very harmful to beneficiaries.” She also highlighted resistance states might face if they adopt block grants, saying, “this is a new use of the Section 1115 demonstration authority and, just as we've seen with work requirements, I would anticipate that litigation will follow. That is a consideration that states will want to have top of mind as they think about the cost and the uncertainty that litigation would present.”
To read the full Q&A, click here.
Orris was also quoted in Inside Health Policy and MedPage Today on this guidance.